Grippo Michael J

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)6%(8%)(24%)0%
Sale Success Rate0 of 82 of 80 of 80 of 80 of 8

Catalent, Inc.

Drugs » Drugs - Generic

SVP, Strategy & Corp. Dev.:

Holdings: 24.45K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--